Charles Schwab Investment Management Inc Bio Sig Technologies, Inc. Transaction History

Charles Schwab Investment Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$1.07 - $1.55 $32,168 - $46,599	30,064 New	30,064 $37,000
Q2 2021 Aug 16, 2021	SELL	$2.94 - $4.75 $190,147 - $307,211	-64,676 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$3.99 - $5.53 $26,956 - $37,360	6,756 Added 11.66%	64,676 $279,000
Q3 2020 Nov 13, 2020	BUY	$4.79 - $9.1 $20,338 - $38,638	4,246 Added 7.91%	57,920 $286,000
Q2 2020 Aug 14, 2020	BUY	$3.61 - $11.84 $45,825 - $150,296	12,694 Added 30.98%	53,674 $387,000

Q3 2019 Nov 08, 2019	BUY	$6.55 - $9.36 $2,475 - $3,538	378 Added 0.93%	40,980 $339,000
Q2 2019 Aug 09, 2019	BUY	$5.92 - $9.47 $240,363 - $384,500	40,602 New	40,602 $382,000

88.5K

Ticker BSGM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,814,400
Market Cap $15.7M
Description
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal ...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.